Idenix Pharmaceuticals LLC and Ors v Gilead Sciences Pty Ltd and Anor

Link copied
Case Copied 1 min read

IDENIX PHARMACEUTICALS LLC & ORS

v

GILEAD SCIENCES PTY LTD & ANOR

[2018] HCASL 83
S12/2018

  1. This application for special leave to appeal does not raise a question of general principle and it is not otherwise in the interests of justice that leave to appeal be granted.  In any event, an appeal to this Court would not enjoy sufficient prospects of success to warrant a grant of special leave to appeal.  The application for special leave to appeal should be dismissed.

  2. Pursuant to r 41.08.1 of the High Court Rules 2004 (Cth), we direct the Registrar to draw up, sign and seal an order dismissing the application with costs.

M.M. Gordon
17 April 2018
J.J. Edelman
CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Idenix Pharmaceuticals LLC and Ors v Gilead Sciences Pty Ltd... and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2018] HCASL 83
Decision Date

CaseChat Overview and Summary

In the case of Idenix Pharmaceuticals LLC and Others versus Gilead Sciences Pty Ltd and Another, the Supreme Court of South Australia was the forum for the original proceedings. This case arose from a dispute between the two parties concerning a patent for a pharmaceutical compound, specifically for its use in treating hepatitis C. The primary issue in the case was whether Gilead Sciences had infringed on a patent held by Idenix Pharmaceuticals. The dispute involved complex issues of patent law and the interpretation of patent claims.

The legal issues that the court needed to decide included the validity of the patent claims, the scope of the patent protection, and whether Gilead Sciences had indeed infringed on the patent. Additionally, the court had to consider whether the patent was validly assigned to Idenix Pharmaceuticals and whether there were any defences available to Gilead Sciences. The case involved detailed technical analysis of the patent claims and a comparison with Gilead's product formulations and methods.

The court concluded that the application for special leave to appeal did not raise a question of general principle and was not in the interests of justice. It found that an appeal to the High Court would not have sufficient prospects of success to warrant a grant of special leave. The court held that the application for special leave to appeal should be dismissed, and pursuant to the High Court Rules 2004, the Registrar was directed to draw up, sign, and seal an order dismissing the application with costs. This decision was based on the court's assessment of the merits and the potential success of the appeal.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

Decision

Reasons for decision

Ratio Decidendi

Legal Principle Established